We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M Turnover 30.95%
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+13.64%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$125M
AUM Growth
+$16.3M
Cap. Flow
+$8.43M
Cap. Flow %
6.73%
Top 10 Hldgs %
37.17%
Holding
71
New
8
Increased
24
Reduced
9
Closed
7
Avg Time Held
1.9 years
Top 10 Avg Time Held
1.5 years
Top 20 Avg Time Held
1.6 years

Top Buys

Rank Stock Value
1
RIGL icon
Rigel Pharmaceuticals
RIGL
+$3.41M
2
TALO icon
Talos Energy
TALO
+$1.71M
3
CPA icon
Copa Holdings
CPA
+$1.58M
4
PK icon
Park Hotels & Resorts
PK
+$1.46M
5
FCX icon
Freeport-McMoran
FCX
+$1.35M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$2.59M
2
BABA icon
Alibaba
BABA
+$2.16M
3
NMRK icon
Newmark Group
NMRK
+$1.3M
4
RVNC icon
Revance Therapeutics, Inc.
RVNC
+$1.03M
5
HAS icon
Hasbro
HAS
+$878K

Sector Composition

Rank Sector Weight
1 Healthcare 39.93%
2 Materials 10.94%
3 Technology 9.96%
4 Industrials 9.07%
5 Financials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CVS icon
26
CVS Health
CVS
$116B
$2.2M 1.76%
35,000
+5,000
+17% +$292K
2024 Q2
1 quarter
PK icon
27
Park Hotels & Resorts
PK
$3.05B
$2.12M 1.69%
150,000
+100,000
+200% +$1.46M
2023 Q1
6 quarters
CHRS icon
28
Coherus Oncology
CHRS
$162M
$2.08M 1.66%
2,000,000
+900,000
+82% +$1.23M
2020 Q4
15 quarters
OGN icon
29
Organon & Co
OGN
$3.61B
$1.91M 1.53%
100,000
-25,000
-20% -$518K
2023 Q2
5 quarters
THFF icon
30
First Financial Corp
THFF
$868M
$1.86M 1.49%
42,500
+2,500
+6% +$106K
2024 Q1
2 quarters
WBA icon
31
DELISTED
Walgreens Boots Alliance
WBA
$1.79M 1.43%
200,000
+50,000
+33% +$514K
2023 Q3
4 quarters
PFE icon
32
Pfizer
PFE
$166B
$1.74M 1.39%
60,000
+10,000
+20% +$292K
2023 Q4
3 quarters
CPA icon
33
Copa Holdings
CPA
$5.35B
$1.64M 1.31%
+17,500
New +$1.58M
2024 Q3
0 quarters
COHU icon
34
Cohu
COHU
$2.76B
$1.54M 1.23%
60,000
+30,000
+100% +$841K
2024 Q2
1 quarter
FCX icon
35
Freeport-McMoran
FCX
$100B
$1.5M 1.2%
+30,000
New +$1.35M
2024 Q3
0 quarters
XOMA icon
36
DELISTED
Xoma
XOMA
$1.46M 1.16%
55,000
– –
2023 Q4
3 quarters
WBD icon
37
DELISTED
Warner Bros
WBD
$1.44M 1.15%
175,000
-25,000
-13% -$195K
2023 Q2
5 quarters
SVC
38
Service Properties Trust
SVC
$758M
$1.37M 1.09%
60,000
– –
2021 Q3
12 quarters
HRI icon
39
Herc Holdings
HRI
$4.12B
$1.28M 1.02%
+8,000
New +$1.13M
2024 Q3
0 quarters
DIT icon
40
AMCON Distributing
DIT
$61.3M
$1.21M 0.96%
12,500
+200
+2% +$19.2K
2020 Q4
15 quarters
CTSO icon
41
Cytosorbents Corp
CTSO
$9.74M
$1.2M 0.96%
40,000
-2,500
-6% -$54.8K
2021 Q1
14 quarters
ACAD icon
42
Acadia Pharmaceuticals
ACAD
$3.32B
$1.08M 0.86%
70,000
+30,000
+75% +$500K
2023 Q4
3 quarters
PRGO icon
43
Perrigo
PRGO
$2.21B
$1.05M 0.84%
+40,000
New +$1.1M
2024 Q3
0 quarters
PAAS icon
44
Pan American Silver
PAAS
$17.6B
$1.04M 0.83%
50,000
-25,000
-33% -$527K
2023 Q2
5 quarters
HRTX icon
45
Heron Therapeutics
HRTX
$68.7M
$995K 0.79%
500,000
+200,000
+67% +$478K
2020 Q4
15 quarters
NKTR icon
46
Nektar Therapeutics
NKTR
$1.26B
$975K 0.78%
50,000
– –
2020 Q4
15 quarters
BATL icon
47
Battalion Oil
BATL
$59M
$934K 0.75%
140,000
– –
2020 Q4
15 quarters
COYA icon
48
Coya Therapeutics
COYA
$98.1M
$929K 0.74%
144,059
+44,059
+44% +$278K
2023 Q2
5 quarters
AVIR icon
49
Atea Pharmaceuticals
AVIR
$371M
$905K 0.72%
270,000
– –
2021 Q2
13 quarters
NWL icon
50
Newell Brands
NWL
$2.33B
$768K 0.61%
100,000
-75,000
-43% -$537K
2023 Q4
3 quarters
1
2
3

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $158M AUM

CM Management's Q3 2024 Portfolio in Review

As of Q3 2024, CM Management held 71 positions worth $125M, up 15% from $109M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CM Management deployed $8.43M of net new capital in Q3 2024, opening 8 new positions and adding to 24 existing holdings. Its largest new stake was Rigel Pharmaceuticals: 290,000 shares worth $4.69M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 36% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was Newmark Group, an estimated $1.3M trimmed.

  • CM Management's largest Q3 2024 buy was Rigel Pharmaceuticals: 290,000 shares worth $4.69M.
  • CM Management added most to Talos Energy in Q3 2024, an estimated $1.71M increase.
  • CM Management's biggest Q3 2024 reduction was Newmark Group, cutting an estimated $1.3M.
  • CM Management fully exited Baidu in Q3 2024, selling an estimated $2.59M.
  • CM Management's ten largest holdings make up 37% of its $125M portfolio in Q3 2024.
  • CM Management opened 8 new positions and closed 7 in Q3 2024.
  • CM Management's portfolio value rose 15% quarter-over-quarter to $125M.

Based on CM Management's 13F filing for Q3 2024, filed 12 Nov 2024.